DBGen awarded an EASI-Genomics grant for innovative long-read sequencing of inherited retinal dystrophies

by DBGen Ocular Genomics

​The Transnational Access Committee of the European Advanced infraStructure for Innovative Genomics (EASI-Genomics) has selected the project PID15251 submitted by DBGen Ocular Genomics in the third ...

Read more

Prometedores datos preliminares del primer CRISPR in vivo en humanos

by Revista Genética Médica

​Investigadores de Intellia Therapeutics, Regeneron Pharmaceuticals y diversos colaboradores internacionales han anunciado resultados prometedores para la edición del genoma mediante CRISPR como tr...

Read more

Pall Corporation Secures Multi-Million Dollar Contract With Exothera

by Pall Biotech

Manufacturing partnership enables suspension-based manufacture of gene therapies and viral vector-based vaccines

Read more

Encouraging advances in therapies for Leber congenital amaurosis

by DBGen Ocular Genomics

Editas Medicine, a company specialising in the development of gene editing therapies, has announced the recruitment of paediatric patients to the Brilliance trial.

Read more

Cancer and dementia research projects funded by the 'la Caixa' Foundation

by Centre for Genomic Regulation

​The “la Caixa” Foundation has funded two research projects at the Centre for Genomic Regulation (CRG) which aim to identify new therapeutic targets for cancer and develop new prevention strateg...

Read more

Identified key alteration in the genes involved in the development of Cornelia de Lange syndrome

by Hospital Universitari de Bellvitge

A study carried out at IDIBELL, led by a research group from IBV-CSIC, published in Nature Communications reveals the molecular bases of Cornelia de Lange syndrome, a rare disease that affects develop...

Read more

Sartorius acquires cell culture specialist Xell AG

by Sartorius Stedim Spain

Extension of the Sartorius cell culture media business with a focus on media for gene therapeutics and vaccines

Read more

Toxicidad inducida al paracetamol para mejorar la eficacia de las terapias génicas dirigidas al hígado

by Revista Genética Médica

Los investigadores han añadido a los componentes de la terapia génica la información para producir un ARN que protege a las células que reciben el tratamiento de la toxicidad generada por dosis el...

Read more

Anticuerpos activables para aumentar la selectividad de las terapias contra tumores cerebrales

by IQS Institut Químic de Sarrià

​ El Glioblastoma Multiforme (GBM) es el tumor cerebral primario más prevalente y con peor pronóstico. Aunque los tratamientos actuales permiten reducir inicialmente el crecimiento del tumor, l...

Read more

DIVERSA: ‘La lucha contra el cáncer continuará, pero tendremos más herramientas’

by BioIncubaTech

Para Blasting Talks– entrevistas exclusivas de Blasting News con líderes empresariales y culturales – entrevistan a Víctor A. Francis, Bussiness Developer de DIVERSA, una spin-off de la Unidad ...

Read more

Researchers at CNIO and 12 de Octubre Hospital prove efficacy of new immunotherapy for multiple myeloma

by CNIO - Centro Nacional de Investigaciones Oncológicas

​The researchers developed a new cancer treatment, called CAR-NK-cell immunotherapy, which instead of T cells uses NK cells, which could be more effective and have fewer side effects

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream